Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (151-160 of 194) with videos related to

Pageof 20
Sort By:
Respiratory Investigation|July 5, 2025
Incidence and clinical significance of acute exacerbation of interstitial lung disease in patients with primary Sjögren's syndromeTomoyuki Fujisawa, Yuko Tanaka, Yosuke Kamiya, et al.
Respiratory Investigation|September 4, 2019
Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidoneMasato Kono, Yutaro Nakamura, Noriyuki Enomoto, et al.
Investigational New Drugs|August 18, 2020
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutationsYoichiro Aoshima, Masato Karayama, Naoki Inui, et al.
Thorax|November 11, 2022
Prognostic significance of radiological pleuroparenchymal fibroelastosis in <i>Mycobacterium avium</i> complex lung disease: a multicentre retrospective cohort studyYuya Aono, Hironao Hozumi, Masato Kono, et al.
Chest|November 7, 2024
Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based AnalysisHironao Hozumi, Yoshinari Endo, Masato Kono, et al.
Respiratory Medicine|April 2, 2018
Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumoniaKatsuhiro Yoshimura, Masato Kono, Yasunori Enomoto, et al.
Respiratory Investigation|October 15, 2021
Transient leukocytopenia following combination therapy for COVID-19Kazuo Tsuchiya, Tomoyuki Fujisawa, Yasutaka Mochizuka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPDYuzo Suzuki, Naoki Inui, Masato Karayama, et al.
The European Respiratory Journal|February 23, 2023
A predictive model for acute exacerbation of idiopathic interstitial pneumoniasMasato Karayama, Yoichiro Aoshima, Takahito Suzuki, et al.
Respirology (Carlton, Vic.)|November 3, 2023
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumoniasTakahito Suzuki, Masato Karayama, Yoichiro Aoshima, et al.
Pageof 20

Showing results (151-160 of 194) with videos related to

Sort By:
Pageof 20
Respiratory Investigation|July 5, 2025
Incidence and clinical significance of acute exacerbation of interstitial lung disease in patients with primary Sjögren's syndromeTomoyuki Fujisawa, Yuko Tanaka, Yosuke Kamiya, et al.
Respiratory Investigation|September 4, 2019
Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidoneMasato Kono, Yutaro Nakamura, Noriyuki Enomoto, et al.
Investigational New Drugs|August 18, 2020
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutationsYoichiro Aoshima, Masato Karayama, Naoki Inui, et al.
Thorax|November 11, 2022
Prognostic significance of radiological pleuroparenchymal fibroelastosis in <i>Mycobacterium avium</i> complex lung disease: a multicentre retrospective cohort studyYuya Aono, Hironao Hozumi, Masato Kono, et al.
Chest|November 7, 2024
Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based AnalysisHironao Hozumi, Yoshinari Endo, Masato Kono, et al.
Respiratory Medicine|April 2, 2018
Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumoniaKatsuhiro Yoshimura, Masato Kono, Yasunori Enomoto, et al.
Respiratory Investigation|October 15, 2021
Transient leukocytopenia following combination therapy for COVID-19Kazuo Tsuchiya, Tomoyuki Fujisawa, Yasutaka Mochizuka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPDYuzo Suzuki, Naoki Inui, Masato Karayama, et al.
The European Respiratory Journal|February 23, 2023
A predictive model for acute exacerbation of idiopathic interstitial pneumoniasMasato Karayama, Yoichiro Aoshima, Takahito Suzuki, et al.
Respirology (Carlton, Vic.)|November 3, 2023
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumoniasTakahito Suzuki, Masato Karayama, Yoichiro Aoshima, et al.
Pageof 20